EOCN Galmed Pharmaceuticals Ltd.
Fundamentals / CIK 0001595353 / USDGalmed Pharmaceuticals Ltd. reported $18.63M in total assets and a net loss of $10.31M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open EOCN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-- Operating profit
-
Net Income FY 2025-$10.31M GAAP bottom line
-
Diluted EPS FY 2025$2.39 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Dec 31, 2025$10.98M Total debt: --
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | $0 | $0 | $2.04M | $1.08M | $467K |
| Research & Development | $4.87M | $2.98M | $3.57M | $12.99M | $27.22M | $26.08M | $18.18M | $8.31M | $9.65M | $14.27M |
| Total Operating Expenses | $8.51M | $6.28M | $7.49M | $17.65M | $32.88M | $30.21M | $22.38M | $10.71M | $12.36M | $16.88M |
| Operating Income | -- | $8.03M | $7.49M | -- | -- | -$30.21M | -$22.38M | -$10.71M | -$12.36M | -$16.88M |
| EBITDA | -- | $8.12M | $7.52M | -- | -- | -$30.17M | -$22.34M | -$10.33M | -$12.12M | -$16.71M |
| Interest Income | -- | -- | -- | -- | -- | $1.19M | $1.95M | $959K | $202K | $382K |
| Income Before Tax | -- | $7.52M | $6.91M | $17.87M | -$32.47M | -$28.77M | -$20.46M | -$9.78M | -$12.30M | -$16.85M |
| Income Tax Expense | $0 | -- | -- | -- | -- | $0 | $0 | $75K | $0 | $106K |
| Net Income | -$10.31M | -$7.52M | -$6.91M | -$17.87M | -$32.47M | -$28.77M | -$20.46M | -$9.86M | -$12.30M | -$16.95M |
| Basic EPS | $2.39 | $8.08 | $30.00 | $127.80 | $237.70 | $16.21 | $11.64 | -- | -- | -- |
| Diluted EPS | $2.39 | $8.08 | $30.00 | $127.80 | $237.70 | -- | -- | -- | -- | -- |
| Basic Shares Outstanding | 4.3M | 930.8K | 230.8K | 139.7K | 136.6K | 1.8M | 1.8M | 1.5M | 1.0M | 947.5K |
| Diluted Shares Outstanding | 4.3M | 930.8K | 230.8K | 139.7K | 136.6K | 1.8M | 1.8M | 1.5M | 1.0M | 947.5K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $3.98M | $4.65M | $2.86M | $2.02M | $2.88M | $6.95M | $15.93M | $24.16M | $13.02M | $3.10M |
| Short-Term Investments | $7.00M | $7.20M | $7.50M | $11.77M | $31.90M | $3.81M | $27.94M | $6.07M | $0 | -- |
| Cash & Short-Term Investments | $10.98M | $11.85M | $10.36M | $13.79M | $34.78M | $10.75M | $43.87M | $30.23M | $13.02M | $3.10M |
| Accounts Receivable, Net | -- | $672K | $480K | $825K | $1.12M | $812K | $827K | $218K | $155K | $284K |
| Total Current Assets | $18.63M | $16.12M | $13.24M | $14.72M | $36.05M | $51.81M | $76.43M | $90.41M | $19.15M | $15.73M |
| Property, Plant & Equipment, Net | -- | -- | $83K | $114K | $145K | $176K | $171K | $194K | $491K | $718K |
| Long-Term Investments | -- | -- | -- | $1.50M | -- | -- | -- | -- | -- | -- |
| Other Non-Current Assets | -- | $257K | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Non-Current Assets | $0 | $2.38M | $3.39M | $1.84M | $551K | $570K | $709K | $194K | $491K | $718K |
| Total Assets | $18.63M | $18.50M | $16.63M | $16.56M | $36.60M | $52.38M | $77.14M | $90.60M | $19.64M | $16.45M |
| Accounts Payable | $2.00M | $1.31M | $1.88M | $2.56M | $4.87M | $7.05M | $6.00M | $1.81M | $2.28M | $3.12M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | $0 | $538K | $1.09M |
| Total Current Liabilities | $2.85M | $2.17M | $2.75M | $3.09M | $5.88M | $8.01M | $6.93M | $2.71M | $3.85M | $4.58M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $796K |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $529K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $44K | $229K | $216K | $352K | $0 | $0 | $796K |
| Total Liabilities | $2.85M | $2.17M | $2.75M | $3.14M | $6.11M | $8.23M | $7.29M | $2.71M | $3.85M | $5.38M |
| Total Debt (incl. Leases) | -- | -- | $41K | $216K | $435K | $419K | $534K | -- | $0 | $796K |
| Common Stock | $3.41M | $742K | $209K | $70K | $70K | $58K | $58K | $58K | $40K | $34K |
| Retained Earnings | -$210.8M | -$200.5M | -$193.0M | -$186.0M | -$168.2M | -$135.7M | -$106.9M | -$86.47M | -$76.62M | -$64.32M |
| Accumulated Other Comp. Income | -$303K | -$416K | -$454K | -$745K | -$171K | $272K | $35K | -$11K | -$7.0K | -$85K |
| Total Stockholders' Equity | $15.78M | $16.33M | $13.88M | $13.42M | $30.50M | $44.15M | $69.85M | $87.89M | $15.79M | $11.07M |
| Total Equity | $15.78M | $16.33M | $13.88M | $13.42M | $30.50M | $44.15M | $69.85M | $87.89M | $15.79M | $11.07M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $3.98M | $4.65M | $2.86M | $2.02M | $2.88M | $6.95M | $15.93M | $24.16M |
| Short-Term Investments | $7.00M | $7.20M | $7.50M | $11.77M | $31.90M | $3.81M | $27.94M | $6.07M |
| Cash & Short-Term Investments | $10.98M | $11.85M | $10.36M | $13.79M | $34.78M | $10.75M | $43.87M | $30.23M |
| Accounts Receivable, Net | -- | $672K | $480K | $825K | $1.12M | $812K | $827K | $218K |
| Total Current Assets | $18.63M | $16.12M | $13.24M | $14.72M | $36.05M | $51.81M | $76.43M | $90.41M |
| Property, Plant & Equipment, Net | -- | -- | $83K | $114K | $145K | $176K | $171K | $194K |
| Long-Term Investments | -- | -- | -- | $1.50M | -- | -- | -- | -- |
| Other Non-Current Assets | -- | $257K | -- | -- | -- | -- | -- | -- |
| Total Non-Current Assets | $0 | $2.38M | $3.39M | $1.84M | $551K | $570K | $709K | $194K |
| Total Assets | $18.63M | $18.50M | $16.63M | $16.56M | $36.60M | $52.38M | $77.14M | $90.60M |
| Accounts Payable | $2.00M | $1.31M | $1.88M | $2.56M | $4.87M | $7.05M | $6.00M | $1.81M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | $0 |
| Total Current Liabilities | $2.85M | $2.17M | $2.75M | $3.09M | $5.88M | $8.01M | $6.93M | $2.71M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $44K | $229K | $216K | $352K | $0 |
| Total Liabilities | $2.85M | $2.17M | $2.75M | $3.14M | $6.11M | $8.23M | $7.29M | $2.71M |
| Total Debt (incl. Leases) | -- | -- | $41K | $216K | $435K | $419K | $534K | -- |
| Common Stock | $3.41M | $742K | $209K | $70K | $70K | $58K | $58K | $58K |
| Retained Earnings | -$210.8M | -$200.5M | -$193.0M | -$186.0M | -$168.2M | -$135.7M | -$106.9M | -$86.47M |
| Accumulated Other Comp. Income | -$303K | -$416K | -$454K | -$745K | -$171K | $272K | $35K | -$11K |
| Total Stockholders' Equity | $15.78M | $16.33M | $13.88M | $13.42M | $30.50M | $44.15M | $69.85M | $87.89M |
| Total Equity | $15.78M | $16.33M | $13.88M | $13.42M | $30.50M | $44.15M | $69.85M | $87.89M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $6.90M | $7.50M | $10.30M | $17.90M | $32.40M | -$28.80M | $20.50M | -$9.86M | -$12.30M | -$16.95M |
| Depreciation & Amortization | -- | $83K | $31K | $35K | $42K | $39K | $35K | $387K | $239K | $169K |
| Stock-Based Compensation | $546K | $531K | $892K | $1.30M | $1.89M | $2.07M | $2.23M | $1.78M | $1.39M | $1.63M |
| Change in Payables | $695K | -$571K | -$681K | -$2.31M | -$2.17M | $1.05M | $4.18M | -$462K | -$846K | $863K |
| Operating Cash Flow | -$6.32M | -$5.88M | -$6.14M | -$18.50M | -$32.89M | -$26.29M | -$14.94M | -$9.02M | -$12.07M | -$12.13M |
| Capital Expenditure | -- | -- | -- | -$4.0K | -$11K | -$44K | -$12K | -$90K | -$12K | -$17K |
| Free Cash Flow | -- | -- | -- | -$18.50M | -$32.90M | -$26.33M | -$14.95M | -$9.11M | -$12.08M | -$12.15M |
| Purchases of Investments | -$6.00M | -$6.00M | -$60.00M | -- | -- | -$55.03M | -$72.60M | -$92.28M | -$3.87M | -- |
| Investing Cash Flow | -$3.38M | -$1.11M | $800K | $17.56M | $11.46M | $16.54M | $6.68M | -$60.02M | $6.44M | $6.34M |
| Common Stock Issued | $7.67M | $4.39M | -- | -- | $9.22M | $707K | -- | -- | $15.02M | $4.48M |
| Financing Cash Flow | $9.03M | $8.79M | $6.18M | $70K | $17.37M | $768K | $143K | $80.18M | $15.55M | $4.73M |
| Net Change in Cash | -$664K | $1.79M | $848K | -$868K | -$4.06M | -$8.98M | -$8.12M | $11.14M | $9.92M | -$1.06M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -- | -- | -- | -- | -- | -- | -- | -525.8% | -1139.5% | -3615.0% |
| Net Profit Margin | -- | -- | -- | -- | -- | -- | -- | -483.6% | -1133.5% | -3630.2% |
| Return on Equity (ROE) | -65.3% | -46.0% | -49.8% | -133.1% | -106.5% | -65.2% | -29.3% | -11.2% | -77.9% | -153.1% |
| Return on Assets (ROA) | -55.3% | -40.6% | -41.6% | -107.9% | -88.7% | -54.9% | -26.5% | -10.9% | -62.6% | -103.1% |
| Current Ratio | 6.55x | 7.42x | 4.81x | 4.76x | 6.13x | 6.47x | 11.02x | 33.41x | 4.98x | 3.44x |
| Quick Ratio | 3.86x | 5.76x | 3.94x | 4.72x | 6.11x | 1.44x | 6.45x | 11.25x | 3.42x | 0.74x |
| Debt to Equity | -- | -- | 0.00x | 0.02x | 0.01x | 0.01x | 0.01x | -- | 0.00x | 0.07x |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | -- | -100.0% | +87.8% | +132.3% | -- |
| Operating Income Growth (YoY) | -- | +7.2% | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -70.4% | -73.1% | -76.5% | -46.2% | +1366.7% | +39.2% | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.